Syntara Limited Corrects Performance Rights Total
PremiumCompany AnnouncementsSyntara Limited Corrects Performance Rights Total
1M ago
Syntara Limited Announces Performance Rights Lapse
Premium
Company Announcements
Syntara Limited Announces Performance Rights Lapse
1M ago
Syntara Limited Plans Incentives for CEO Retention
Premium
Company Announcements
Syntara Limited Plans Incentives for CEO Retention
1M ago
Pharmaxis Nears Myelofibrosis Study Goals Amidst Legal Dispute
PremiumCompany AnnouncementsPharmaxis Nears Myelofibrosis Study Goals Amidst Legal Dispute
2M ago
Syntara Limited’s Latest Cash Flow Report
Premium
Company Announcements
Syntara Limited’s Latest Cash Flow Report
2M ago
Pharmaxis Ltd Announces Upcoming Equity Raise
Premium
Company Announcements
Pharmaxis Ltd Announces Upcoming Equity Raise
2M ago
Syntara Limited Showcases at Investor Webinar
PremiumCompany AnnouncementsSyntara Limited Showcases at Investor Webinar
4M ago
Syntara Limited Announces New ASX Securities
Premium
Company Announcements
Syntara Limited Announces New ASX Securities
5M ago
Pharmaxis Outlines Potential Amidst Uncertainties
Premium
Company Announcements
Pharmaxis Outlines Potential Amidst Uncertainties
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100